Skip to main content
. 2023 Aug;62(2):291–299. doi: 10.20471/acc.2023.62.02.06

Table 5. Features of patients stratified by the presence of bronchoscopy-related complications.

Complication
    (n=55)
    No complication (n=88)     p
    Age     68.92±9.55     68.61±11.22     0.864
    Gender (male)     29 (52.7%)     59 (67.0%)     0.087
    Apache-II     17.70±4.27     13.03±3.04     <0.001
    PaO2 (mm Hg)     61.51±3.61     61.53±4.77     0.969
    PaO2/FiO2     179.58±24.10     191.54±30.12     0.010
    Comorbid conditions
    Hypertension     39 (70.9%)     60 (68.2%)     0.731
    Diabetes mellitus     17 (30.9%)     20 (22.7%)     0.277
    Obstructive lung disease     17 (30.9%)     27 (30.7%)     0.977
    Chronic heart disease*     29 (52.7%)     31 (35.2%)     0.039
    Chronic renal failure     14 (25.5%)     23 (26.1%)     0.928
    Neurological disease#     19 (34.5%)     37 (42.0%)     0.371
    Malignancy**     7 (12.7%)     14 (15.9%)     0.601
    Bronchoscopy sample
    Bronchial lavage     35 (63.6%)     68 (77.3%)     0.077
    Bronchoalveolar lavage     19 (34.5%)     16 (18.2%)     0.027
    Bronchial biopsy     4 (7.3%)     6 (6.8%)     0.917
    Respiratory support during
    conventional oxygen     29 (52.7%)     52 (59.1%)     0.455
    Noninvasive ventilation     2 (3.6%)     8 (9.1%)     0.317
    High flow nasal oxygen     4 (7.3%)     9 (10.2%)     0.550
    Invasive mechanical ventilation     20 (36.4%)     19 (21.6%)     0.054
    *heart failure, coronary artery disease, cardiac valve pathologies; **non-small-cell lung cancer, colon cancer, stomach cancer, mandibular squamous cell cancer, prostate cancer and mesothelioma; #dementia, multiple sclerosis, Parkinson’s disease, stroke and epilepsy; Apache-II = Acute Physiology and Chronic Health Evaluation; PaO2 = partial pressure of oxygen; FiO2 = fraction of inspired oxygen